Drug selection for sedation and general anesthesia in children undergoing ambulatory magnetic resonance imaging

키워드

참고문헌 (85)

1. Uffman JC, "MRI utilization and the associated use of sedation and anesthesia in a pediatric ACO", J Am Coll Radiol, 14, pp.924~930 (2017)
2. Wachtel RE, "Growth rates in pediatric diagnostic imaging and sedation", Anesth Analg, 108, pp.1616~1621 (2009)
3. Dial S, "Pediatric sedation for procedures titrated to a desired degree of immobility results in unpredictable depth of sedation", Pediatr Emerg Care, 17, pp.414~420 (2001)
4. Kaila R, "Postdischarge adverse events related to sedation for diagnostic imaging in children", Pediatr Emerg Care, 28, pp.796~801 (2012)
5. "Continuum of depth of sedation: definition of general anesthesia and levels of sedation/analgesia" (2019)[URL]
6. Cote CJ, "Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures", Pediatrics, 143, pp.e20191000~ (2019)
7. Nedoma J, "Vital sign monitoring and cardiac triggering at 1.5 tesla: a practical solution by an MR-ballistocardiography fiber-optic sensor", Sensors(Basel), 19, pp.470~ (2019)
8. Kamat PP, "Pediatric critical care physician-administered procedural sedation using propofol : a report from the Pediatric Sedation Research Consortium Database", Pediatr Crit Care Med, 16, pp.11~20 (2015)
9. Sanborn PA, "Adverse cardiovascular and respiratory events during sedation of pediatric patients for imaging examinations", Radiology, 237, pp.288~294 (2005)
10. Mayers DJ, "Chloral hydrate disposition following single-dose administration to critically ill neonates and children", Dev Pharmacol Ther, 16, pp.71~77 (1991)
11. Litman RS, "Chloral hydrate sedation in term and preterm infants : an analysis of efficacy and complications", Anesth Analg, 110, pp.739~746 (2010)
12. Ratnapalan S, "Chloral hydrate sedation in children", Clin Pediatr(Phila), 53, pp.933~936 (2014)
13. "Sedation in under 19s: using sedation for diagnostic and therapeutic procedures (Clinical guideline CG112)" (2010)[URL]
14. Low E, "Sedation with oral chloral hydrate in children undergoing MRI scanning", Ir Med J, 101, pp.80~82 (2008)
15. Lee YJ, "Analysis of the appropriate age and weight for pediatric patient sedation for magnetic resonance imaging", Am J Emerg Med, 30, pp.1189~1195 (2012)
16. Malviya S, "Pentobarbital vs chloral hydrate for sedation of children undergoing MRI : efficacy and recovery characteristics", Paediatr Anaesth, 14, pp.589~595 (2004)
17. Dalal PG, "Sedation and anesthesia protocols used for magnetic resonance imaging studies in infants : provider and pharmacologic considerations", Anesth Analg, 103, pp.863~868 (2006)
18. Cortellazzi P, "Sedation of neurologically impaired children undergoing MRI : a sequential approach", Paediatr Anaesth, 17, pp.630~636 (2007)
19. Delgado J, "Chloral hydrate in pediatric magnetic resonance imaging : evaluation of a 10-year sedation experience administered by radiologists", Pediatr Radiol, 45, pp.108~114 (2015)
20. Greenberg SB, "High-dose chloral hydrate sedation for children undergoing MR imaging : safety and efficacy in relation to age", AJR Am J Roentgenol, 161, pp.639~641 (1993)
21. Finnemore A, "Chloral hydrate sedation for magnetic resonance imaging in newborn infants", Paediatr Anaesth, 24, pp.190~195 (2014)
22. Mace SE, "Clinical policy : critical issues in the sedation of pediatric patients in the emergency department", Ann Emerg Med, 51, pp.378~399 (2008)
23. Lipshitz M, "Chloral hydrate side effects in young children : causes and management", Heart Lung, 22, pp.408~414 (1993)
24. Schulte-Uentrop L, "Anaesthesia or sedation for MRI in children", Curr Opin Anaesthesiol, 23, pp.513~517 (2010)
25. Ehrnebo M, "Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration", J Pharm Sci, 63, pp.1114~1118 (1974)
26. Mason KP, "Infant sedation for MR imaging and CT : oral versus intravenous pentobarbital", Radiology, 233, pp.723~728 (2004)
27. Mallory MD, "Propofol vs pentobarbital for sedation of children undergoing magnetic resonance imaging : results from the Pediatric Sedation Research Consortium", Paediatr Anaesth, 19, pp.601~611 (2009)
28. Greenberg SB, "Initial experience with intravenous pentobarbital sedation for children undergoing MRI at a tertiary care pediatric hospital : the learning curve", Pediatr Radiol, 30, pp.689~691 (2000)
29. Mason KP, "Superiority of pentobarbital versus chloral hydrate for sedation in infants during imaging", Radiology, 230, pp.537~542 (2004)
30. Schlatter J, "Oral pentobarbital suspension for children sedation during MR imaging", Ann Pharm Fr, 76, pp.286~290 (2018)
31. Rooks VJ, "Comparison of oral pentobarbital sodium(nembutal)and oral chloral hydrate for sedation of infants during radiologic imaging : preliminary results", AJR Am J Roentgenol, 180, pp.1125~1128 (2003)
32. Ross AK, "Moderate sedation for MRI in young children with autism", Pediatr Radiol, 35, pp.867~871 (2005)
33. Kannikeswaran N, "Utility of endtidal carbon dioxide monitoring in detection of hypoxia during sedation for brain magnetic resonance imaging in children with developmental disabilities", Paediatr Anaesth, 21, pp.1241~1246 (2011)
34. Boriosi JP, "Safety and efficacy of buccal dexmedetomidine for MRI sedation in school-aged children", Hosp Pediatr, 9, pp.348~354 (2019)
35. Sulton C, "The use of intranasal dexmedetomidine and midazolam for sedated magnetic resonance imaging in children : a report from the Pediatric Sedation Research Consortium", Pediatr Emerg Care, 36, pp.138~142 (2020)
36. Ibrahim M, "A prospective, randomized, double blinded comparison of intranasal dexmedetomodine vs intranasal ketamine in combination with intravenous midazolam for procedural sedation in school aged children undergoing MRI", Anesth Essays Res, 8, pp.179~186 (2014)
37. Pershad J, "Comparison of propofol with pentobarbital", midazolam, Pediatrics, pp.2007, 120[DOI]
38. D'Agostino J, "Chloral hydrate versus midazolam for sedation of children for neuroimaging : a randomized clinical trial", Pediatr Emerg Care, 16, pp.1~4 (2000)
39. Rupprecht T, "Sedation and monitoring of paediatric patients undergoing open low-field MRI", Acta Paediatr, 89, pp.1077~1081 (2000)
40. Mazurek MS, "Sedation and analgesia for procedures outside the operating room", Semin Pediatr Surg, 13, pp.166~173 (2004)
41. Shannon M, "Safety and efficacy of flumazenil in the reversal of benzodiazepine-induced conscious sedation. The Flumazenil Pediatric Study Group", J Pediatr, 131, pp.582~586 (1997)
42. White PF, "Ketamine : its pharmacology and therapeutic uses", Anesthesiology, 56, pp.119~136 (1982)
43. Kim JG, "Combination of dexmedetomidine and ketamine for magnetic resonance imaging sedation", Front Neurol, 10, pp.416~ (2019)
44. Tomatir E, "Effects of low dose ketamine before induction on propofol anesthesia for pediatric magnetic resonance imaging", Paediatr Anaesth, 14, pp.845~850 (2004)
45. Schmitz A, "Sedation for magnetic resonance imaging using propofol with or without ketamine at induction in pediatrics : a prospective randomized double-blinded study", Paediatr Anaesth, 28, pp.264~274 (2018)
46. Mahmoud M, "Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations", Br J Anaesth, 115, pp.171~182 (2015)
47. Mahmoud M, "A comparison of dexmedetomidine with propofol for magnetic resonance imaging sleep studies in children", Anesth Analg, 109, pp.745~753 (2009)
48. Sriganesh K, "Airway dimensions in children with neurological disabilities during dexmedetomidine and propofol sedation for magnetic resonance imaging study", Turk J Anaesthesiol Reanim, 46, pp.214~221 (2018)
49. Bloor BC, "Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes", Anesthesiology, 77, pp.1134~1142 (1992)
50. Philipp M, "Physiological significance of alpha(2)-adrenergic receptor subtype diversity : one receptor is not enough", Am J Physiol Regul Integr Comp Physiol, 283, pp.R287~R295 (2002)
51. Mason KP, "Hemodynamic response to fluid management in children undergoing dexmedetomidine sedation for MRI", AJR Am J Roentgenol, 202, pp.W574~W579 (2014)
52. Mason KP, "An exaggerated hypertensive response to glycopyrrolate therapy for bradycardia associated with high-dose dexmedetomidine", Anesth Analg, 108, pp.906~908 (2009)
53. Mason KP, "High dose dexmedetomidine as the sole sedative for pediatric MRI", Paediatr Anaesth, 18, pp.403~411 (2008)
54. Ebert TJ, "The effects of increasing plasma concentrations of dexmedetomidine in humans", Anesthesiology, 93, pp.382~394 (2000)
55. Boriosi JP, "Safety and efficacy of buccal dexmedetomidine for MRI sedation in school-aged children", Hosp Pediatr, 9, pp.348~354 (2019)
56. Tug A, "Comparison of two different intranasal doses of dexmedetomidine in children for magnetic resonance imaging sedation", Paediatr Drugs, 17, pp.479~485 (2015)
57. Teshome G, "Comparison of dexmedetomidine with pentobarbital for pediatric MRI sedation", Hosp Pediatr, 4, pp.360~365 (2014)
58. Belleville JP, "Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate", Anesthesiology, 77, pp.1125~1133 (1992)
59. Konig MW, "Influence of anesthetic management on quality of magnetoencephalography scan data in pediatric patients : a case series", Paediatr Anaesth, 19, pp.507~512 (2009)
60. Roback MG, "Update on pharmacological management of procedural sedation for children", Curr Opin Anaesthesiol, 29(Suppl 1), pp.S21~S35 (2016)
61. Machata AM, "Propofol-based sedation regimen for infants and children undergoing ambulatory magnetic resonance imaging", Br J Anaesth, 101, pp.239~243 (2008)
62. Gutmann A, "Propofol anesthesia in spontaneously breathing children undergoing magnetic resonance imaging : comparison of two propofol emulsions", Paediatr Anaesth, 16, pp.266~274 (2006)
63. Cho JE, "Titrated propofol induction vs. continuous infusion in children undergoing magnetic resonance imaging", Acta Anaesthesiol Scand, 54, pp.453~457 (2010)
64. Hassan NE, "Randomized controlled trial for intermittent versus continuous propofol sedation for pediatric brain and spine magnetic resonance imaging studies", Pediatr Crit Care Med, 12, pp.e262~e265 (2011)
65. Abdallah C, "MR-compatible pumps versus manual titration of propofol for pediatric sedation", J Med Eng Technol, 34, pp.443~447 (2010)
66. Zhou Q, "Dexmedetomidine versus propofol on the sedation of pediatric patients during magnetic resonance imaging(MRI)scanning : a meta-analysis of current studies", Oncotarget, 8, pp.102468~102473 (2017)
67. Ahmed SS, "Dexmedetomidine versus propofol : is one better than the other for MRI sedation in children", J Pediatr Intensive Care, 6, pp.117~122 (2017)
68. Fang H, "Clinical efficacy of dexmedetomidine versus propofol in children undergoing magnetic resonance imaging : a meta-analysis", Int J Clin Exp Med, 8, pp.11881~11889 (2015)
69. Wu J, "Comparison of propofol and dexmedetomedine techniques in children undergoing magnetic resonance imaging", Paediatr Anaesth, 24, pp.813~818 (2014)
70. Bryan YF, "A randomized trial comparing sevoflurane and propofol in children undergoing MRI scans", Paediatr Anaesth, 19, pp.672~681 (2009)
71. Mallory MD, "Emergency physician-administered propofol sedation: a report on 25,433 sedations from the pediatric sedation research consortium", Ann Emerg Med, 57, pp.462~468 (2011)
72. Cravero JP, "The incidence and nature of adverse events during pediatric sedation", anesthesia with propofol for procedures outside the operating room : a report from the Pediatric Sedation Research Consortium, 2009, pp.108, 795~804
73. Srinivasan M, "Procedural sedation for diagnostic imaging in children by pediatric hospitalists using propofol: analysis of the nature, frequency, and predictors of adverse events and interventions", J Pediatr, 160, pp.801~806 (2012)
74. Picard P, "Prevention of pain on injection with propofol : a equantitative systematic review", Anesth Analg, 90, pp.963~969 (2000)
75. Murphy A, "Allergic reactions to propofol in egg-allergic children", Anesth Analg, 113, pp.140~144 (2011)
76. Kol IO, "Open-label, prospective, randomized comparison of propofol and sevoflurane for laryngeal mask anesthesia for magnetic resonance imaging in pediatric patients", Clin Ther, 30, pp.175~181 (2008)
77. Tsui BC, "Combined propofol and remifentanil intravenous anesthesia for pediatric patients undergoing magnetic resonance imaging", Paediatr Anaesth, 15, pp.397~401 (2005)
78. Lutterbey G, "Atelectasis in children undergoing either propofol infusion or positive pressure ventilation anesthesia for magnetic resonance imaging", Paediatr Anaesth, 17, pp.121~125 (2007)
79. Sury MR, "Sevoflurane sedation in infants undergoing MRI : a preliminary report", Paediatr Anaesth, 15, pp.16~22 (2005)
80. De Sanctis Briggs V, "Magnetic resonance imaging under sedation in newborns and infants : a study of 640 cases using sevoflurane", Paediatr Anaesth, 15, pp.9~15 (2005)
81. Lei H, "Serious airway-related adverse events with sevoflurane anesthesia via facemask for magnetic resonance imaging in 7129 pediatric patients : a retrospective study", Paediatr Anaesth, 29, pp.635~639 (2019)
82. Blitman NM, "Pulmonary atelectasis in children anesthetized for cardiothoracic MR : evaluation of risk factors", J Comput Assist Tomogr, 31, pp.789~794 (2007)
83. Mongodi S, "Ten-year experience with standardized non-operating room anesthesia with Sevoflurane for MRI in children affected by neuropsychiatric disorders", BMC Anesthesiol, 19, pp.235~ (2019)
84. Schultheis LW, "Pediatric drug development in anesthesiology : an FDA perspective", Anesth Analg, 103, pp.49~51 (2006)
85. Gore R, "Pediatric off-label and unlicensed drug use and its implications", Curr Clin Pharmacol, 12, pp.18~25 (2017)